Clinical Trials Directory

Trials / Completed

CompletedNCT01602744

The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital

The Use of STOPP/START Criteria for Medication Intervention and the Risk of Falls, Hospitalization, Functioning and Quality of Life Among Elderly Population Living in a Geriatric Hospital in Israel and Comparison to Beers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
382 (actual)
Sponsor
Wolfson Medical Center · Other Government
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if the use of STOPP/START criteria (STOPP-screening tool of older persons potentially inappropriate prescriptions START-screening tool to alert doctors to right treatment)for medication intervention in elderly population living in a geriatric hospital will lower the number of falls,hospitalization,will improve functioning, quality of life and reduce financial costs.

Detailed description

Inappropriate prescribing is common in older people and is associated with adverse drug effects,hospitalization and falls. In this trial we want to check the efficacy of the screening tools STOPP/START which were developed and validated in order to reduce inappropriate prescribing. STOPP comprises of 65 indicators of drug-drug, drug-disease interactions and therapeutic duplication. START incorporates 22 evidence based indicators of common prescribing omissions. We will conduct a randomized controlled trial to test the hypothesis that screening the medications of older patients living permanently in a geriatric hospital will improve their quality of life. The compliance of the doctor working in the geriatric hospital to the recommendations of the screening tools will also be checked.

Conditions

Interventions

TypeNameDescription
OTHERSTOPP/START screening tools for medication interventionIn the intervention arm the investigator will use the screening tools STOPP/START to screen the medications.

Timeline

Start date
2012-04-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2012-05-21
Last updated
2014-04-16
Results posted
2014-03-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01602744. Inclusion in this directory is not an endorsement.